Kirkland & Ellis Expands M&A Strength With Addition Of Graham Robinson, Laura Knoll And Chadé Severin
Kirkland & Ellis Expands M&A Strength With Addition Of Graham Robinson, Laura Knoll And Chadé Severin
Kirkland & Ellis has welcomed Graham Robinson, Laura Knoll, and Chadé Severin as partners in its M&A practice, further enhancing its strength in public company M&A with a special focus on the biotechnology sector.
All three attorneys are renowned for their work on high-value and complex transactions. Their move marks a significant addition to Kirkland’s powerhouse public company M&A group, particularly in biotech, where they have established themselves as market leaders.
Graham Robinson has advised some of the world’s largest pharmaceutical, medical device, and tech companies. According to Deal Point Data, he ranks first by deal value and volume in U.S. public biotech M&A transactions since January 2016. His practice includes preparing companies for unsolicited acquisition proposals, shareholder activism, corporate governance, and internal investigations. He has been recognized by Chambers Global, Chambers USA, The Best Lawyers in America (Boston M&A Lawyer of the Year, 2023), and was named a 2024 Law360 MVP in Life Sciences.
Graham Robinson said, “I could not be more excited for this next chapter of my career,The Kirkland M&A platform is a great fit for our practice, and I look forward to contributing to the continued success of the Firm’s M&A team and the Boston office.”
Laura Knoll advises both public and private companies on transformative M&A transactions and critical governance matters, particularly in the biopharmaceutical and tech sectors. She is recognized by Chambers USA, The Best Lawyers in America, and The Legal 500 U.S., and was named a Law360 Rising Star in Life Sciences in 2020.
Chadé Severin brings significant experience in M&A involving public and private companies, with particular expertise in deals involving controlling shareholders. Her practice is concentrated in the pharmaceutical, biotech, and tech sectors. She was named a winner in the “New Leaders in the Law” category by the 2024 New England Legal Awards and a Law360 Rising Star in Life Sciences in 2021.
Jon A. Ballis, Chairman of Kirkland & Ellis said, “Graham, Laura and Chadé are among the nation’s leading M&A lawyers and the market-leaders for biotech M&A, We’re thrilled that they are joining Kirkland and adding more strength to our leading M&A practice.”
Graham Robinson, Laura Knoll and Chadé Severin are among the nation’s leading M&A lawyers and the market leaders for biotech M&A. We’re thrilled that they have joined Kirkland, adding more strength to our leading M&A practice.
Christian Atwood Partner said, "I’m SO excited about this (also, watch this space . . . more to come). A truly great day for Kirkland & Ellis generally and the hashtag#Boston office specifically. Have wanted to work with this team for a long time now, and couldn’t be happier to call Graham Robinson, Laura Knoll and Chadé Severin my partners."
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.
